Cranial Nerves IX-XII Contouring Atlas for Head and Neck Cancer
CRANIAL NERVES ATLAS
Waleed F. Mourad, MD, Kenneth S. Hu MD, Louis B. Harrison MD
Department of Radiation Oncology
Beth Israel Medical Centers (BIMC)
St. Luke's-Roosevelt Hospital (SLRH)
Continuum Cancer Centers of New York (CCCNY)
Montefiore Medical Center
Albert Einstein College of Medicine (Einstein)
special thanks to
Brett Young, MD, and Jill K. Gregory, CMI, FAMI
DAHANCA, EORTC, GORTEC, NCIC and RTOG Endorsed Consensus Guidelines for the Delineation of the CTV in the N0 Neck of Patients with Head & Neck Squamous Cell Carcinoma
CONSENSUS ATLAS FOR CT-BASED DELINEATION OF NODAL REGIONS IN THE N0 NECK - 2013 UPDATE
CONSENSUS GUIDELINE FOR NODAL LEVEL DELINEATION IN THE N0 NECK - 2013 UPDATE
Prof. Vincent GREGOIRE, Radiation Oncology Dept., Universite Catholique de Louvain, St-Luc University Hospital, Brussels, BELGIUM
Prof. Peter LEVENDAG, Radiation Oncology Dept., Erasmus Medical Center, Rotterdam,THE NETHERLAND
Collaborators:
Kian K. Ang (1), Radiation Oncology; Bahman Emami (1), Radiation Oncology; Jacques Bernier (2), Radiation Oncology; Adam Garden (1), Radiation Oncology; Marijel Braaksma (3), Radiation Oncology; Cai Grau (6), Radiation Oncology; Volker Budach (4), Radiation Oncology; Marc Hamoir (5), Head & Neck Surgery; Cliff Chao (1), Radiation Oncology; Nancy Lee (1), Radiation Oncology; Emmanuel Coche (5), Radiology; Philippe Maingon (7), Radiation Oncology; Jay Cooper (1), Radiation Oncology; Karin Muller (3), Radiation Oncology; Guy Cosnard (5), Radiology; Herve Reychler (5), Maxillo-facial Surgery; Avraham Eisbruch (1), Radiation Oncology
6 DAHANCA, 4 EORTC radiotherapy group, 2 EORTC H&N group, 3 Erasmus Medical Center, 7 GORTEC, 1 RTOG H&N group, 5 UCL St-Luc University Hospital
Disclaimer:
The materials presented in this website illustrates the consensus reached among cooperatives groups with respect to the delineation of the lymph node levels in the node negative neck. Authors are not responsible for any use of these guidelines by third parties.